Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DASTY
426
DELISTED
DASSAULT SYSTEMES SA ADR
DASTY
| $3.66M | ﹤0.01% |
99,742
-255
| -0.3% | -$9.36K |
|
427
Huazhu Hotels Group
HTHT
$13B
| $3.65M | ﹤0.01% |
95,890
| – | – |
|
428
Installed Building Products
IBP
$6.51B
| $3.5M | ﹤0.01% |
42,044
-4
| -0% | -$342 |
|
429
Check Point Software Technologies
CHKP
$12.8B
| $3.45M | ﹤0.01% |
28,295
+685
| +2% | +$87.9K |
|
430
Warner Bros
WBD
$65.1B
| $3.41M | ﹤0.01% |
254,294
-57,304
| -18% | -$1.06M |
|
|
CDMO
431
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.38M | ﹤0.01% |
221,693
+13,551
| +7% | +$200K |
|
432
Icon
ICLR
$12.6B
| $3.37M | ﹤0.01% |
15,564
-103
| -0.7% | -$23.1K |
|
433
Northern Trust
NTRS
$33.7B
| $3.35M | ﹤0.01% |
34,726
-10,750
| -24% | -$1.14M |
|
434
First Merchants
FRME
$2.72B
| $3.29M | ﹤0.01% |
92,508
| – | – |
|
|
MNRL
435
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $3.28M | ﹤0.01% |
133,087
-55,396
| -29% | -$1.53M |
|
436
iShares Russell 1000 Growth ETF
IWF
$127B
| $3.26M | ﹤0.01% |
59,656
+3,384
| +6% | +$203K |
|
437
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
| $3.22M | ﹤0.01% |
38,402
+4,150
| +12% | +$379K |
|
|
ESTE
438
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $3.21M | ﹤0.01% |
235,325
-122,397
| -34% | -$1.93M |
|
439
8x8 Inc
EGHT
$328M
| $3.19M | ﹤0.01% |
619,087
+143,273
| +30% | +$1.2M |
|
440
Quanex
NX
$959M
| $3.15M | ﹤0.01% |
138,385
+12,022
| +10% | +$251K |
|
441
PetMed Express
PETS
$42.1M
| $3.14M | ﹤0.01% |
157,944
+29,261
| +23% | +$654K |
|
442
Micron Technology
MU
$1.01T
| $3.14M | ﹤0.01% |
56,814
-519
| -0.9% | -$35.2K |
|
443
Incyte
INCY
$24.3B
| $3.12M | ﹤0.01% |
41,069
+4,518
| +12% | +$343K |
|
444
Worthington Enterprises
WOR
$2.87B
| $3.03M | ﹤0.01% |
111,573
+472
| +0.4% | +$13.7K |
|
|
TMHC
445
DELISTED
Taylor Morrison
TMHC
| $3M | ﹤0.01% |
128,318
-10
| -0% | -$265 |
|
446
IBM
IBM
$222B
| $2.91M | ﹤0.01% |
20,611
-2,310
| -10% | -$312K |
|
447
M/I Homes
MHO
$3.81B
| $2.91M | ﹤0.01% |
73,352
| – | – |
|
448
Alkermes
ALKS
$8.32B
| $2.9M | ﹤0.01% |
97,325
+12,680
| +15% | +$364K |
|
449
AptarGroup
ATR
$8.69B
| $2.9M | ﹤0.01% |
28,054
-19,602
| -41% | -$2.14M |
|
450
iShares Semiconductor ETF
SOXX
$47.6B
| $2.85M | ﹤0.01% |
24,417
+657
| +3% | +$88.6K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.